A phase 2b randomised, double-blind, parallel-group study of alginate oligosaccharide (OligoG) dry powder inhalation in addition to standard of care compared to placebo in addition to standard of care in patients with Cystic Fibrosis (CF).

  • Wilson, John (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date23/05/19 → 31/12/20

Keywords

  • Cystic Fibrosis
  • Allergy
  • Immunology
  • Clinical trial